Insider Trading History of Schwartz Jeffrey Lawrence

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Schwartz Jeffrey Lawrence since 2020. This trader's CIK number is 1702957. At the time of last reporting, Schwartz Jeffrey Lawrence was the Director of Springworks Therapeutics, Inc.. (stock ticker symbol SWTX). Also see all insider trading activities at Springworks Therapeutics, Inc..

Note that in the past Schwartz Jeffrey Lawrence also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Annexon, Inc. (ANNX) by Schwartz Jeffrey Lawrence

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 ANNX 400,000 $6,800,000 0 $0 0 $0

Yearly summary of insider trading at Arcutis Biotherapeutics, Inc. (ARQT) by Schwartz Jeffrey Lawrence

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 ARQT 294,117 $4,999,989 0 $0 0 $0

Yearly summary of insider trading at Springworks Therapeutics, Inc. (SWTX) by Schwartz Jeffrey Lawrence

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 SWTX 0 $0 1,750,000 $49,875,000 0 $0


Insider trading activities at 3 companies by Schwartz Jeffrey Lawrence:

1. Annexon, Inc. (ANNX)

2. Arcutis Biotherapeutics, Inc. (ARQT)

3. Springworks Therapeutics, Inc. (SWTX)

Table 1. Insider trading of Annexon, Inc. (ANNX) by Schwartz Jeffrey Lawrence

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-07-28 ANNX Buy 400,000 17.00 6,800,000

Table 2. Insider trading of Arcutis Biotherapeutics, Inc. (ARQT) by Schwartz Jeffrey Lawrence

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-02-04 ARQT Buy 294,117 17.00 4,999,989

Table 3. Insider trading of Springworks Therapeutics, Inc. (SWTX) by Schwartz Jeffrey Lawrence

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-03-16 SWTX Sale 1,750,000 28.50 49,875,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schwartz Jeffrey Lawrence (Director of Springworks Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.